GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » OncoZenge AB (OSTO:ONCOZ) » Definitions » Dividend Yield %

OncoZenge AB (OSTO:ONCOZ) Dividend Yield % : 0.00% (As of Mar. 30, 2025)


View and export this data going back to 2021. Start your Free Trial

What is OncoZenge AB Dividend Yield %?

As of today (2025-03-30), the Trailing Annual Dividend Yield of OncoZenge AB is 0.00%.

The historical rank and industry rank for OncoZenge AB's Dividend Yield % or its related term are showing as below:

OSTO:ONCOZ's Dividend Yield % is not ranked *
in the Biotechnology industry.
Industry Median: 1.4
* Ranked among companies with meaningful Dividend Yield % only.

OncoZenge AB's Dividend Payout Ratio for the three months ended in Dec. 2024 was 0.00.

As of today (2025-03-30), the Forward Dividend Yield % of OncoZenge AB is 0.00%.

OncoZenge AB's Dividends per Share for the three months ended in Dec. 2024 was kr0.00.

The growth rate is calculated with least square regression.

For more information regarding to dividend, please check our Dividend Page.

* Please note that "special dividend" is not included in the calculation of dividend per share and related fields.


OncoZenge AB Dividend Yield % Historical Data

The historical data trend for OncoZenge AB's Dividend Yield % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

OncoZenge AB Dividend Yield % Chart

OncoZenge AB Annual Data
Trend Dec20 Dec21 Dec22 Dec23 Dec24
Dividend Yield %
- - - - -

OncoZenge AB Quarterly Data
Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24
Dividend Yield % Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only - - - - -

Competitive Comparison of OncoZenge AB's Dividend Yield %

For the Biotechnology subindustry, OncoZenge AB's Dividend Yield %, along with its competitors' market caps and Dividend Yield % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


OncoZenge AB's Dividend Yield % Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, OncoZenge AB's Dividend Yield % distribution charts can be found below:

* The bar in red indicates where OncoZenge AB's Dividend Yield % falls into.


;
;

OncoZenge AB Dividend Yield % Calculation

Dividend Yield measures how much a company pays out in dividends each year relative to its share price.


OncoZenge AB  (OSTO:ONCOZ) Dividend Yield % Explanation

Over the long term, the return from dividends has been a significant contributor to the total returns produced by equity securities. Studies by Elroy Dimson, Paul Marsh, and Mike Staunton of Princeton University (2002) found that a market-oriented portfolio, which included reinvested dividends, would have generated nearly 85 times the wealth generated by the same portfolio relying solely on capital gains.

Dividends may also qualify a lower tax rate for investors.

In dividends investing, Payout Ratio and Dividend Growth Rate are the two most important variables for consideration. A lower payout ratio may indicate that the company has more room to increase its dividends.

You can find the stocks that owned most by Gurus here. Or you can check out Warren Buffett's highest dividend stocks here.


OncoZenge AB Dividend Yield % Related Terms

Thank you for viewing the detailed overview of OncoZenge AB's Dividend Yield % provided by GuruFocus.com. Please click on the following links to see related term pages.


OncoZenge AB Business Description

Traded in Other Exchanges
Address
Gustavslundsvagen 34, Bromma, SWE, 167 51
OncoZenge AB is a pharmaceutical company that is developing a new treatment for effective pain relief in patients suffering from oral pain caused by radiation therapy and chemotherapy for cancer. In phase 2 patient studies, the company's product candidate BupiZenge displayed pain relief compared with standard therapy. It focuses on implementing a phase development program as a basis for regulatory approvals and product launches.

OncoZenge AB Headlines

No Headlines